DIAMEDICA THERAPEUTICS INC's ticker is DMAC and the CUSIP is 25253X207. A total of 23 filers reported holding DIAMEDICA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $2,376,000 | -20.6% | 1,176,344 | -1.7% | 1.10% | -11.0% |
| Q1 2022 | $2,993,000 | -32.8% | 1,197,245 | +0.2% | 1.24% | -39.3% |
| Q4 2021 | $4,456,000 | +570.1% | 1,194,670 | +620.7% | 2.04% | +574.9% |
| Q3 2021 | $665,000 | -64.4% | 165,775 | -60.5% | 0.30% | -69.0% |
| Q2 2021 | $1,869,000 | -80.0% | 419,942 | -59.0% | 0.98% | -80.7% |
| Q1 2021 | $9,364,000 | -2.8% | 1,023,409 | +7.7% | 5.06% | -31.4% |
| Q4 2020 | $9,633,000 | +98.2% | 950,000 | -17.1% | 7.38% | +45.8% |
| Q3 2020 | $4,861,000 | +4.9% | 1,146,470 | +71.5% | 5.06% | -43.6% |
| Q2 2020 | $4,632,000 | +100.4% | 668,430 | -19.0% | 8.97% | +267.1% |
| Q1 2020 | $2,311,000 | +8153.6% | 825,297 | +5921.9% | 2.44% | +8951.9% |
| Q3 2019 | $28,000 | -97.5% | 13,705 | -94.5% | 0.03% | -95.9% |
| Q1 2019 | $1,135,000 | – | 250,000 | – | 0.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 1,146,470 | $4,861,000 | 5.06% |
| Corriente Advisors, LLC | 730,000 | $3,095,000 | 1.57% |
| Manatuck Hill Partners, LLC | 571,500 | $2,423,000 | 1.11% |
| CVI Holdings, LLC | 276,176 | $1,171,000 | 0.48% |
| DAFNA Capital Management LLC | 156,529 | $664,000 | 0.22% |
| Worth Venture Partners, LLC | 42,887 | $182,000 | 0.15% |
| Granite Point Capital Management, L.P. | 646,855 | $2,743,000 | 0.15% |
| Ikarian Capital, LLC | 415,000 | $1,759,000 | 0.13% |
| Maven Securities LTD | 359,285 | $1,473,000 | 0.12% |
| Nantahala Capital Management | 756,193 | $3,206,000 | 0.10% |